West Pharma (WST) Tops Q2 EPS by 27c; Trims Outlook
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $336.39 +2.03%
EPS Growth %: +13.0%
Financial Fact:
Research and development: 9M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: +13.0%
Financial Fact:
Research and development: 9M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
West Pharma (NYSE: WST) reported Q2 EPS of $2.48, $0.27 better than the analyst estimate of $2.21. Revenue for the quarter came in at $771.3 million versus the consensus estimate of $755.08 million.
GUIDANCE:
West Pharma sees FY2022 EPS of $9.00-$9.12, versus the consensus of $9.32.
For earnings history and earnings-related data on West Pharma (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- Cerebras Systems posts 94% revenue jump, announces OpenAI deal
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
